Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 15, 2001The Journal of Infectious DiseasesOpen Access

In Vivo Clearance of Glucuronoxylomannan, the Major Capsular Polysaccharide ofCryptococcus neoformans:A Critical Role for Tissue Macrophages

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMatthew M. GrinsellVirginia Commonwealth UniversityLWL C WeinholdJCJim E. CutlerTulane University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Grinsell et al. (2001) studied this question.

synapsesocial.com/papers/6a7af729b2ad017e403236e8https://doi.org/10.1086/322787
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness1977 · 123 citations
  2. 2Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation1995 · 104 citations
  3. 3Polysaccharide antigens of the capsule of Cryptococcus neoformans1994 · 325 citations
  4. 4Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis1992 · 636 citations
  5. 5Effect of Immune Mechanisms on the Pharmacokinetics and Organ Distribution of Cryptococcal Polysaccharide1998 · 54 citations